Physiopathological mechanisms in type 1 and type 2 diabetes

被引:0
|
作者
Boitard, C
机构
[1] Hop Cochin, Serv Immunodiabetol, F-75674 Paris, France
[2] Hop Cochin, INSERM, U561, F-75674 Paris, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 1 and type 2 diabetes have different clinical presentations in their common forms. The absence of biological tests for diagnosis of type 2 diabetes. for reliable evaluation of insulin secretion and. beta-cell mass or for diagnosis insulitis and the limited sensitivity of antibody tests in type 1 diabetes explain the difficulty of classifying a large number of cases of diabetes and the identification of questionable clinical entities: LADA (Latent Autoimmune Diabetes in Adult). non-insulin dependant diabetes in coloured people. Hyperglycaemia may also be observed in genetic diseases affecting insulin secretion (MODY. mutations of mitochondrial DNA). complex genetic diseases. pancreatic. endocrine and iatrogenic affections. Type 1 diabetes is characterised by the destruction of, beta-cells while type 2 diabetes combines abnormal insulin secretion and insulin resistance. The reduction of the beta-cell mass in type 2 diabetes remains controversial. These different conditions are examples of multifactorial diseases during which several physiopathological processes are disturbed in association with the expression of multiple genes. of normal structure and function. but variants of which copy for a number of partial phenotypes the association of which causes the disease. Some hypotheses suggest that type 2 diabetes is the consequence of the selection of variants of genes involved in energetic storing and responsible for defence against infection and of the recent very rapid changes in the environment.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
  • [1] Mechanisms of platelet hyperreactivity in type 1 and type 2 diabetes
    Giubilato, S.
    Pitocco, D.
    Leo, A.
    Riondino, S.
    Musella, T.
    Biasucci, L. M.
    Crea, F.
    Pulcinelli, F.
    Ghirlanda, G.
    DIABETOLOGIA, 2007, 50 : S484 - S485
  • [2] Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms
    Daniel Gonzalez Izundegui
    Matthew Nayor
    Current Diabetes Reports, 2022, 22 : 65 - 76
  • [3] Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms
    Izundegui, Daniel Gonzalez
    Nayor, Matthew
    CURRENT DIABETES REPORTS, 2022, 22 (02) : 65 - 76
  • [4] Mechanisms and early patterns of dyslipidemia in pediatric type 1 and type 2 diabetes
    Nwosu, Benjamin Udoka
    Villalobos-Ortiz, Tony R.
    Jasmin, Gabrielle A.
    Parajuli, Sadichchha
    Zitek-Morrison, Emily
    Barton, Bruce A.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (11): : 1399 - 1408
  • [5] DISTINGUISHING BETWEEN TYPE 1 AND TYPE 2 DIABETES Evolving type 1 diabetes in distinguishing between type 1 and type 2 diabetes
    Hill, N. E.
    Oliver, N. S.
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
  • [7] Type 1 on type 2 diabetes mellitus: Autoimmune type 1 diabetes superimposed on established type 2 diabetes
    Suzuki, Takahiro
    Takahashi, Kenji
    Miyamoto, Satoshi
    Ueno, Hiroyuki
    Takekawa, Sato
    Yoshida, Atsushi
    Fujita, Motohiro
    INTERNAL MEDICINE, 2007, 46 (24) : 1957 - 1962
  • [8] Autoimmune mechanisms in type 1 diabetes
    Knip, Mikael
    Siljander, Heli
    AUTOIMMUNITY REVIEWS, 2008, 7 (07) : 550 - 557
  • [9] Immune mechanisms in type 1 diabetes
    Wallberg, Maja
    Cooke, Anne
    TRENDS IN IMMUNOLOGY, 2013, 34 (12) : 583 - 591
  • [10] β-Cell failure in diabetes: Common susceptibility and mechanisms shared between type 1 and type 2 diabetes
    Ikegami, Hiroshi
    Babaya, Naru
    Noso, Shinsuke
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (09) : 1526 - 1539